Domesco Medical Import Export JSC (STC:DMC) Cyclically Adjusted Revenue per Share: ₫52,530.66 (As of Mar. 2026)


STC:DMC Domesco Medical Import Export JSC STC:DMC
77 GF Score
Price ₫58,000.00
GF Value ₫73,698.20
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Domesco Medical Import Export JSC Cyclically Adjusted Revenue per Share?

Domesco Medical Import Export JSC STC:DMC 77 Cyclically Adjusted Revenue per Share is ₫52,530.66 as of Mar. 2026. GuruFocus rates STC:DMC with a GF Score™ of 77/100 and a GF Value™ of ₫73,698.20 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Domesco Medical Import Export JSC's adjusted revenue per share for the three months ended in Mar. 2026 was ₫14,962.143. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₫52,530.66 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Domesco Medical Import Export JSC's average Cyclically Adjusted Revenue Growth Rate was 4.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Domesco Medical Import Export JSC was 1.90% per year. The lowest was 1.50% per year. And the median was 1.70% per year.

As of today (2026-07-09), Domesco Medical Import Export JSC's current stock price is ₫58000.00. Domesco Medical Import Export JSC's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₫52,530.66. Domesco Medical Import Export JSC's Cyclically Adjusted PS Ratio of today is 1.10.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Domesco Medical Import Export JSC was 1.68. The lowest was 0.84. And the median was 1.20.


Domesco Medical Import Export JSC  (STC:DMC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Domesco Medical Import Export JSC's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=58000.00/52530.66
=1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Domesco Medical Import Export JSC was 1.68. The lowest was 0.84. And the median was 1.20.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Domesco Medical Import Export JSC Cyclically Adjusted Revenue per Share Related Terms


Domesco Medical Import Export JSC Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Domesco Medical Import Export JSC's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Domesco Medical Import Export JSC Cyclically Adjusted Revenue per Share Chart

Domesco Medical Import Export JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46,580.02 48,993.76 48,603.47 49,354.60 51,176.38

Domesco Medical Import Export JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50,349.33 50,800.59 51,396.56 51,176.38 52,530.66

STC:DMC vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Domesco Medical Import Export JSC's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Domesco Medical Import Export JSC Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Domesco Medical Import Export JSC's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Domesco Medical Import Export JSC's Cyclically Adjusted PS Ratio falls into.


STC:DMC
77GF Score
Domesco Medical Import Export JSC STC:DMC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Domesco Medical Import Export JSC Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Domesco Medical Import Export JSC's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=14962.143/330.2130*330.2130
=14,962.143

Current CPI (Mar. 2026) = 330.2130.

Domesco Medical Import Export JSC Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 11,671.887 241.018 15,991.373
201609 8,796.057 241.428 12,030.802
201612 11,271.411 241.432 15,416.210
201703 8,026.739 243.801 10,871.709
201706 8,556.244 244.955 11,534.294
201709 9,104.393 246.819 12,180.541
201712 11,282.519 246.524 15,112.664
201803 8,418.481 249.554 11,139.440
201806 8,470.452 251.989 11,099.903
201809 8,887.359 252.439 11,625.468
201812 11,844.110 251.233 15,567.537
201903 8,917.586 254.202 11,584.106
201906 10,507.729 256.143 13,546.295
201909 10,766.515 256.759 13,846.616
201912 12,088.036 256.974 15,533.193
202003 8,360.946 258.115 10,696.368
202006 11,158.351 257.797 14,292.767
202009 9,512.298 260.280 12,068.098
202012 12,770.598 260.474 16,189.783
202103 8,360.873 264.877 10,423.211
202106 10,460.384 271.696 12,713.307
202109 11,164.251 274.310 13,439.469
202112 13,159.876 278.802 15,586.553
202203 10,344.139 287.504 11,880.771
202206 11,488.740 296.311 12,803.208
202209 9,777.085 296.808 10,877.472
202212 12,528.244 296.797 13,938.783
202303 11,676.748 301.836 12,774.533
202306 10,356.727 305.109 11,208.866
202309 11,528.103 307.789 12,367.984
202312 12,150.259 306.746 13,079.791
202403 12,070.641 312.332 12,761.685
202406 13,295.649 314.175 13,974.365
202409 10,962.388 315.301 11,480.849
202412 13,965.588 315.605 14,611.995
202503 13,509.063 319.799 13,948.975
202506 14,694.274 322.561 15,042.861
202509 12,941.888 324.800 13,157.573
202512 13,684.978 324.054 13,945.076
202603 14,962.143 330.213 14,962.143

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₫52,530.66 mean?
Domesco Medical Import Export JSC (STC:DMC) has a Cyclically Adjusted Revenue per Share of ₫52,530.66 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Domesco Medical Import Export JSC and its competitors.
Is Domesco Medical Import Export JSC's Cyclically Adjusted Revenue per Share too high?
Domesco Medical Import Export JSC's current Cyclically Adjusted Revenue per Share is ₫52,530.66. Overall, Domesco Medical Import Export JSC has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Domesco Medical Import Export JSC's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Domesco Medical Import Export JSC's Cyclically Adjusted Revenue per Share of ₫52,530.66 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Domesco Medical Import Export JSC and its competitors. Domesco Medical Import Export JSC's current Cyclically Adjusted Revenue per Share is ₫52,530.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Domesco Medical Import Export JSC stock overvalued right now?
Based on GuruFocus' analysis, Domesco Medical Import Export JSC (STC:DMC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫73,698.20, compared to a current price of ₫58,000.00 — trading 21.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₫52,530.66. Domesco Medical Import Export JSC's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Domesco Medical Import Export JSC (STC:DMC), the current Cyclically Adjusted Revenue per Share is ₫52,530.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Domesco Medical Import Export JSC (STC:DMC) Overvalued in 2026?

Based on GuruFocus' analysis, Domesco Medical Import Export JSC stock appears to be undervalued. The current stock price of ₫58,000.00 is trading 21.3% below its estimated GF Value™ of ₫73,698.20. GuruFocus considers Domesco Medical Import Export JSC to be Modestly Undervalued.

Key valuation signals for STC:DMC:

  • Cyclically Adjusted Revenue per Share: ₫52,530.66
  • GF Value™: ₫73,698.20 vs. price of ₫58,000.00 (21.3% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the STC:DMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Domesco Medical Import Export JSC Business Description

Address No. 346, Nguyen Hue street, My Tra Ward, Cao Lanh City, Dong Thap, VNM
Domesco Medical Import Export JSC is specialized in research, development, production, marketing and trading of Pharmaceuticals, medicines derived from Pharmaceutical materials, functional food, pure drinking water and medical beverages. It operates in import and export of medicines, medicine materials, food - functional foods, medical supplies, and medical equipment for medical examination and treatment for the whole people.
77GF Score

Get the complete analysis for STC:DMC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫58,000.00
Price
₫73,698.20
GF Value